Savant Capital’s Exact Sciences EXAS Stock Holding History

Savant Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,045	Closed	-$411K	–	1525
2025 Q4	$411K	Buy	+4,045	New	+$325K	﹤0.01%	917
2024 Q4	–	Sell	-10,162	Closed	-$692K	–	1450
2024 Q3	$692K	Buy	+10,162	New	+$574K	0.01%	761
2024 Q2	–	Sell	-23,729	Closed	-$1.64M	–	1287
2024 Q1	$1.64M	Buy	23,729 +20,865	+729%	+$1.32M	0.02%	407
2023 Q4	$212K	Sell	2,864 -752	-21%	-$49.3K	﹤0.01%	803
2023 Q3	$247K	Buy	3,616 +753	+26%	+$63.9K	﹤0.01%	709
2023 Q2	$269K	Buy	+2,863	New	+$223K	﹤0.01%	675
2021 Q2	–	Sell	-1,592	Closed	-$210K	–	502
2021 Q1	$210K	Buy	+1,592	New	+$218K	0.01%	437

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Savant Capital's EXAS Position: Q1 2026 in Review

Savant Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,045 shares — an estimated $411K sold.

Savant Capital first reported a position in EXAS in Q1 2021 and held it in 7 quarters. The position peaked at $1.64M in Q1 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Savant Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Savant Capital sold 4,045 Exact Sciences shares in Q1 2026, an estimated $411K.
Savant Capital first reported a position in Exact Sciences in Q1 2021 and held it in 7 quarters.
Savant Capital's Exact Sciences position peaked at $1.64M in Q1 2024.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.